Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06042556 · ClinicalTrials.gov registry record · NA
IUD Self-Removal: Evaluating an Online Guide for Self-removal in Clinical and Non-clinical Settings
A NA study of Contraception and IUD, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 116
- Enrollment target
- 1
- Study location
NCT06042556: Completed NA study of Contraception and IUD, sponsored by University of Washington.
NCT06042556 is a NA study of Contraception and IUD that has completed, run by University of Washington. The registered enrollment target is 116 participants, below the 453-participant average among 72 other Contraception trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06042556, a NA study of Contraception and IUD, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 116 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators previously developed a guide to help people with IUD self-removal. In this randomized study, the goal is to see if this guide makes it easier for IUD-users to remove their own IUDs. The main question the study aims to answer is: -Does use of the previously developed IUD self-removal guide increase rates of self removal? Participants will: * Complete a pre-study survey * Be randomized to self-removal with use of the guide or no additional resource * Self-select participation at home or in clinic * Attempt IUD self-removal either at home or in clinic * Complete a post-study survey. Investigators will compare rates of successful self-removal between those randomized to the guide to those randomized to no additional resource to see if increases success.
Primary Outcome
Successful self-removal will be reported by participants on the post-study survey and documented with an uploaded photo of the removed IUD on a study ruler sheet. Rates of successful self-removal will be compared between those randomized to the guide versus no additional resource.
Conditions Studied
Interventions
- OTHER IUD self-removal guide
Study Locations (1)
Washington
- Cedar River Clinics - Renton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2021-04-03 |
| Est. Completion | 2023-02-16 |
| Phase | NA |
What the finished NCT06042556 record still lists
NCT06042556 is an interventional study that assigns participants to a tested intervention. The registered 116 participants enrollment target is mid-sized for trials with a published cap, below the 453-participant average among 72 other Contraception trials with a reported enrollment target (74% lower).
The record links to 2 conditions, with Contraception appearing as the primary indexed condition, and to 1 intervention - of which IUD self-removal guide is the first listed.
NCT06042556 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT06042556 about?
NCT06042556 is a clinical study titled "IUD Self-Removal: Evaluating an Online Guide for Self-removal in Clinical and Non-clinical Settings". Investigators previously developed a guide to help people with IUD self-removal. In this randomized study, the goal is to see if this guide makes it easier for IUD-users to remove their own IUDs. The main question the study aims to answer is: -Does use of the previously developed IUD self-removal ...
What is the current status of trial NCT06042556?
This trial is currently completed. It is a NA study. The enrollment target is 116 participants. The study started on 2021-04-03. Estimated completion is 2023-02-16.
What conditions does trial NCT06042556 study?
This clinical trial studies the following conditions: Contraception, IUD.
What interventions are being tested in trial NCT06042556?
The interventions under investigation include: IUD self-removal guide (OTHER).
Who is sponsoring clinical trial NCT06042556?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06042556 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contraception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06042556's enrollment target sits among peer trials
116 43rd of 72 higher than 30 of 72 other Contraception trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Contraception trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Patient-clinical Linkages to Improve Trust and Engagement in Postpartum Healthcare
RECRUITING · NA
-
Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements
RECRUITING · NA
-
Hormonal Contraception Access Through Pharmacist Prescribing Implementation
RECRUITING · NA
-
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
RECRUITING · NA
-
Contraceptive Efficacy Study of Ovaprene
RECRUITING · NA
-
Intervening on Women's Health for Rural Young Cancer Survivors
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03014687 · 116 participants · Phase 4
Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions
- NCT03214562 · 116 participants · Phase 1
Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia
- NCT03847467 · 116 participants · Phase 1
Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
- NCT04222413 · 116 participants · Phase 1
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI